دورية أكاديمية

Evolutionary immuno-genetics of endoplasmic reticulum aminopeptidase II (ERAP2).

التفاصيل البيبلوغرافية
العنوان: Evolutionary immuno-genetics of endoplasmic reticulum aminopeptidase II (ERAP2).
المؤلفون: Raja A; Department of Ophthalmology, Center for Translational Immunology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands., Kuiper JJW; Department of Ophthalmology, Center for Translational Immunology, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands. j.j.w.kuiper@umcutrecht.nl.
المصدر: Genes and immunity [Genes Immun] 2023 Dec; Vol. 24 (6), pp. 295-302. Date of Electronic Publication: 2023 Nov 04.
نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100953417 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5470 (Electronic) Linking ISSN: 14664879 NLM ISO Abbreviation: Genes Immun Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Houndmills, Basingstoke, Hampshire, UK : Nature Pub. Group,
مواضيع طبية MeSH: Aminopeptidases*/genetics , Aminopeptidases*/immunology , Endoplasmic Reticulum*/enzymology , Evolution, Molecular* , Adaptive Immunity*/genetics, Humans ; Autoimmune Diseases/genetics ; Autoimmune Diseases/immunology ; Haplotypes ; Minor Histocompatibility Antigens/genetics
مستخلص: Endoplasmic reticulum aminopeptidase 2 (ERAP2) is a proteolytic enzyme involved in adaptive immunity. The ERAP2 gene is highly polymorphic and encodes haplotypes that confer resistance against lethal infectious diseases, but also increase the risk for autoimmune disorders. Identifying how ERAP2 influences susceptibility to these traits requires an understanding of the selective pressures that shaped and maintained allelic variation throughout human evolution. Our review discusses the genetic regulation of haplotypes and diversity in naturally occurring ERAP2 allotypes in the global population. We outline how these ERAP2 haplotypes evolved during human history and highlight the presence of Neanderthal DNA sequences in ERAP2 of modern humans. Recent evidence suggests that human adaptation during the last ~10,000 years and historic pandemics left a significant mark on the ERAP2 gene that determines susceptibility to infectious and inflammatory diseases today.
(© 2023. The Author(s).)
References: PLoS Genet. 2014 Mar 27;10(3):e1004189. (PMID: 24675550)
Science. 2013 Mar 29;339(6127):1578-82. (PMID: 23413192)
Front Immunol. 2020 Nov 11;11:599558. (PMID: 33262772)
Front Immunol. 2022 Sep 20;13:1002375. (PMID: 36203608)
J Biol Chem. 2021 Jan-Jun;296:100443. (PMID: 33617882)
PLoS Genet. 2014 May 08;10(5):e1004353. (PMID: 24809476)
Nat Genet. 2021 Oct;53(10):1415-1424. (PMID: 34594039)
PLoS Genet. 2009 Dec;5(12):e1000766. (PMID: 20011102)
Nat Ecol Evol. 2023 Jun;7(6):939-953. (PMID: 37142741)
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17594-9. (PMID: 25422414)
Int J Mol Sci. 2020 Dec 17;21(24):. (PMID: 33348540)
Hum Mol Genet. 2018 Dec 15;27(24):4333-4343. (PMID: 30215709)
Hum Immunol. 2019 May;80(5):310-317. (PMID: 30414458)
Curr Biol. 2019 Sep 9;29(17):2926-2935.e4. (PMID: 31402299)
Mol Biol Evol. 2020 Nov 1;37(11):3267-3291. (PMID: 32462188)
J Biol Chem. 2003 Aug 22;278(34):32275-83. (PMID: 12799365)
Ann Rheum Dis. 2023 Jul;82(7):887-896. (PMID: 36987655)
Nat Ecol Evol. 2019 Aug;3(8):1253-1264. (PMID: 31358949)
Nature. 2018 Jun;558(7708):73-79. (PMID: 29875488)
Nature. 2022 Nov;611(7935):312-319. (PMID: 36261521)
Hum Mol Genet. 2014 Nov 15;23(22):6081-7. (PMID: 24957906)
Cell. 2017 Feb 23;168(5):916-927.e12. (PMID: 28235201)
Curr Opin Genet Dev. 2014 Dec;29:45-51. (PMID: 25173959)
PLoS Genet. 2021 Sep 27;17(9):e1009493. (PMID: 34570765)
Biochim Biophys Acta. 2005 Aug 1;1751(1):9-18. (PMID: 16054015)
Arthritis Rheumatol. 2017 Mar;69(3):686. (PMID: 28239991)
Genome Biol Evol. 2023 Mar 3;15(3):. (PMID: 36821771)
Genome Res. 2018 Dec;28(12):1812-1825. (PMID: 30446528)
PLoS Biol. 2020 Jan 17;18(1):e3000586. (PMID: 31951611)
FEBS J. 2005 Feb;272(4):916-28. (PMID: 15691326)
Curr Opin Immunol. 2023 Aug;83:102337. (PMID: 37216842)
Cells. 2020 Aug 24;9(9):. (PMID: 32847031)
Cell. 2018 Oct 4;175(2):360-371.e13. (PMID: 30290142)
Front Immunol. 2020 Jul 23;11:1576. (PMID: 32793222)
Am J Hum Genet. 2023 Apr 6;110(4):691-702. (PMID: 36889308)
Mol Biol Evol. 2016 Jun;33(6):1435-47. (PMID: 26831942)
Nature. 2015 Oct 1;526(7571):68-74. (PMID: 26432245)
Genome Biol Evol. 2018 Mar 1;10(3):939-955. (PMID: 29608730)
J Immunol. 2012 Sep 1;189(5):2383-92. (PMID: 22837489)
PLoS Genet. 2010 Oct 14;6(10):e1001157. (PMID: 20976248)
Front Immunol. 2018 Oct 30;9:2463. (PMID: 30425713)
Hum Mol Genet. 2010 Dec 1;19(23):4705-14. (PMID: 20843824)
Front Immunol. 2021 Feb 25;12:634441. (PMID: 33717175)
Mol Immunol. 2023 Feb;154:61-68. (PMID: 36608422)
Nucleic Acids Res. 2022 Jan 7;50(D1):D988-D995. (PMID: 34791404)
Mol Immunol. 2020 May;121:7-19. (PMID: 32135401)
Nature. 2023 May;617(7962):755-763. (PMID: 37198480)
Nat Immunol. 2005 Jul;6(7):689-97. (PMID: 15908954)
Cell Genom. 2023 Jan 13;3(2):100248. (PMID: 36819665)
Cell Genom. 2022 Nov 9;2(11):. (PMID: 36465279)
معلومات مُعتمدة: 954992 EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions)
المشرفين على المادة: EC 3.4.11.- (Aminopeptidases)
EC 3.4.11.- (ERAP2 protein, human)
0 (Minor Histocompatibility Antigens)
تواريخ الأحداث: Date Created: 20231105 Date Completed: 20240112 Latest Revision: 20240625
رمز التحديث: 20240626
مُعرف محوري في PubMed: PMC10721543
DOI: 10.1038/s41435-023-00225-8
PMID: 37925533
قاعدة البيانات: MEDLINE
الوصف
تدمد:1476-5470
DOI:10.1038/s41435-023-00225-8